Structure-Activity Relationships and Drug Design
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Mechanistic Models: Overview of Compartment Models
Pharmacovigilance
Pharmacokinetic Models: Comparison and Selection Criterion
Pharmacokinetic Models: Overview
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Zhongyu Mou1, Patra Volarath1, Rebecca Racz1
1FDA Center for Drug Evaluation and Research (CDER), Silver Spring, Maryland 20903, United States.
新模型预测药物诱导的心脏毒性,这是药物开发失败的主要原因. 这些工具评估各种心脏风险,帮助药物发现和安全性评估.
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: